72 Results for "

Generalized

" in MedChemExpress (MCE) Product Catalog:
Products (72)

72 Results for "Generalized" in MCE Product Catalog:

Cat. No.: HY-120627
CAS No.: 477930-31-7
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

BMS-442606, the S-enantiomer of 6-hydroxybuspirone (6OHB), is an orally active 5-HT1A partial agonist. BMS-442606 can be used for generalized anxiety disorder (GAD) research .
loading...
    loading...
Cat. No.: HY-N15656
CAS No.: 25991-81-5
Swertinin (Compound 3) is an antianxiety. Swertinin can be isolated from stems of Kielmeyera coriacea. Swertinin can be used for anxiety disorders, such as generalized anxiety and panic disorders research .
loading...
    loading...
Cat. No.: HY-19046A
CAS No.: 53873-21-5
Synonyms: SC 48274; BTG 1501
Research Areas:  

Neurological Disease

AGN‑2979 (SC 48274; BTG 1501) is an orally active and selective tryptophan hydroxylase inhibitor with antidepressant-like and anxiolytic-like activities. AGN‑2979 inhibits stress-induced activation of tryptophan hydroxylase, thereby limiting the biosynthesis of 5-hydroxytryptamine in the brain. AGN-2979 possesses non-sedative anxiolytic and cognitive-enhancing properties. AGN-2979 is applicable to research related to depression and generalized anxiety disorder .
loading...
    loading...
Cat. No.: HY-182571
CAS No.: 15437-29-3
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

AK-42 is a selective CLC-2 chloride channel inhibitor with human IC50 of 17 nM and rat IC50 of 14 nM. AK-42 binds to an extracellular vestibule above the channel pore, inhibits CLC-2 currents acutely and reversibly, including with auxiliary subunit GlialCAM coexpression. AK-42 acts as a selective tool compound for acute CLC-2 function modulation to probe CLC-2 neurophysiology. AK-42 can be used for the research of leukodystrophy and idiopathic generalized epilepsies .
loading...
    loading...
Cat. No.: HY-171182
CAS No.: 130403-18-8
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease

D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy .
loading...
    loading...
Cat. No.: HY-131286
CAS No.: 441765-98-6
Synonyms: LY-544344
Target:  

mGluR

Research Areas:  

Neurological Disease

Talaglumetad (LY-544344) is an orally active prodrug of Eglumegad (HY-18941) and a metabotropic glutamate receptor 2/3 (mGluR2/3) agonist. Talaglumetad undergoes transmembrane transport via the intestinal peptide transporter hPepT1, and is enzymatically hydrolyzed to produce L-alanine and the parent drug Eglumegad after entering the body. Talaglumetad can be used in research related to metabotropic glutamate receptor 2-associated neurological systems .
loading...
    loading...
Cat. No.: HY-119716
CAS No.: 7199-29-3
Research Areas:  

Neurological Disease

Cyheptamide is an orally active anticonvulsant and antiepileptic agent. Cyheptamide exhibits moderate acute toxicity in animal models, with lethal doses varying by species specificity. Cyheptamide can be used in studies related to convulsions and epilepsy .
loading...
    loading...
Cat. No.: HY-122272A
CAS No.: 72471-80-8
Synonyms: BRL29060 acetate
Paroxetine (BRL29060) acetate is an orally active and selective serotonin reuptake inhibitor (SSRI) and apoptosis inducer with blood-brain barrier permeability. Paroxetine acetate inhibits nitric oxide synthase and CYP2D6, induces desensitization of 5-HT1A/1B/1D autoreceptors, downregulates 5-HT2 receptors, and promotes the production of inflammatory cytokines. Paroxetine acetate is a weak norepinephrine (NE) uptake inhibitor and possesses antitumor activity. Paroxetine acetate is widely used in research concerning depression, obsessive-compulsive disorder, panic disorder, social phobia, generalized anxiety disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, hot flashes, and related conditions .
loading...
    loading...
Cat. No.: HY-182472
CAS No.: 478132-11-5
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

AL-38022A is a potent and selective 5-HT2 receptor agonist (Ki ≤2.2 nM), but a significantly lower (>100-fold less) affinity for other 5-HT receptors. AL-38022A potently stimulates functional responses via 5-HT2 receptor subtypes including [Ca 2+]i mobilization and tissue contractions with apparently similar potencies and intrinsic activities. AL-38022A fully generalizes to the (±)-1-(2,5-dimethoxy 4-methylphenyl)-2-aminopropane hydrochloride (DOM) stimulus in drug discrimination paradigms. AL-38022A can be used for the glaucoma research .
loading...
    loading...
Cat. No.: HY-19682A
CAS No.: 68576-88-5
Research Areas:  

Neurological Disease

Enciprazine dihydrochloride is an orally active non-benzodiazepine anxiolytic. Enciprazine dihydrochloride acts as an agonist of 5-HT1A receptor (5-HT1AR) and an antagonist of α1-adrenergic receptor (α1-adrenergic receptor) . Enciprazine dihydrochloride induces drug-related electroencephalogram changes by reducing the average power of δ waves and θ waves, and increasing the average power of α waves and fast β waves. Enciprazine dihydrochloride exhibits anti-aggressive activity, with only weak sedative and ataxic effects. Enciprazine dihydrochloride regulates plasma corticosterone levels and activates the hypothalamic-pituitary-adrenal axis. Enciprazine dihydrochloride can be used in research related to anxiety disorders, generalized anxiety syndrome and psychosis .
loading...
    loading...
Cat. No.: HY-186034
CAS No.: 2138445-51-7
Research Areas:  

Neurological Disease

R06039-691 is a neuropeptide S receptor (NPSR) agonist with an EC50 of 93 nM. By activating NPSR, R06039-691 participates in the regulation of multiple biological functions including arousal, stress and anxiety responses, memory processes, and food intake. R06039-691 can be used for research on NPSR-related diseases such as anxiety, insomnia, narcolepsy, and cognitive impairment .
loading...
    loading...
Cat. No.: HY-187836
CAS No.: 3109711-34-1
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

WO170 is a KCNT1 inhibitor that can be used in studies related to diseases associated with KCNT1 dysfunction, such as epilepsy .
loading...
    loading...